Wutah pendapatan taun lumaku: novavax.com (NVAX)

Logo perusahaan publik Novavax Pharma (NVAX)

Novavax, Inc. (NVAX) reduces capital expenditures by utilizing external partners for vaccine development and production, with the metric currently standing at -61.00. The current 12-month year-over-year sales trend illustrates revenue dynamics. Diversification of logistics routes ensures supply stability, while patent protection and strict facility certification create barriers to entry for new players.

NVAX (Novavax) riwayat Wutah dodolan YoY (TTM) saka 11.02.2024 nganti 18.11.2026

novavax.com (NVAX) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental perusahaan:Novavax, Inc. - NVAX
Produk sing diprodhuksi Novavax, Inc.

The investment attractiveness of Novavax, Inc. (NVAX) depends on the ability of the remaining core research team to monetize the current product pipeline. This indicator calculates the daily rolling revenue growth over the last twelve months, which allows this chart of LTM sales volume changes compared to the previous year to identify cooling demand and assess the real efficiency of business management following staff optimization.